Clearstead Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $96.9K | Sell |
766
-151
| -16% | -$19.1K | ﹤0.01% | 1068 |
|
|
2025
Q1 | $117K | Sell |
917
-85
| -8% | -$10.9K | ﹤0.01% | 946 |
|
|
2024
Q4 | $132K | Hold |
1,002
| – | – | ﹤0.01% | 951 |
|
|
2024
Q3 | $146K | Buy |
1,002
+1
| +0.1% | +$146 | ﹤0.01% | 937 |
|
|
2024
Q2 | $137K | Buy |
1,001
+149
| +17% | +$20.5K | ﹤0.01% | 926 |
|
|
2024
Q1 | $115K | Sell |
852
-263
| -24% | -$35.3K | 0.01% | 579 |
|
|
2023
Q4 | $152K | Sell |
1,115
-1,115
| -50% | -$152K | 0.01% | 499 |
|
|
2023
Q3 | $273K | Buy |
2,230
+1,475
| +195% | +$180K | 0.01% | 502 |
|
|
2023
Q2 | $95.9K | Hold |
755
| – | – | 0.01% | 585 |
|
|
2023
Q1 | $97.5K | Hold |
755
| – | – | 0.01% | 513 |
|
|
2022
Q4 | $99.1K | Buy |
755
+105
| +16% | +$13.8K | 0.01% | 496 |
|
|
2022
Q3 | $76K | Buy |
650
+215
| +49% | +$25.1K | 0.01% | 521 |
|
|
2022
Q2 | $51K | Sell |
435
-200
| -31% | -$23.4K | ﹤0.01% | 615 |
|
|
2022
Q1 | $83K | Hold |
635
| – | – | 0.01% | 582 |
|
|
2021
Q4 | $97K | Buy |
635
+200
| +46% | +$30.6K | 0.01% | 529 |
|
|
2021
Q3 | $70K | Hold |
435
| – | – | 0.01% | 553 |
|
|
2021
Q2 | $71K | Hold |
435
| – | – | 0.01% | 507 |
|
|
2021
Q1 | $65K | Hold |
435
| – | – | 0.01% | 508 |
|
|
2020
Q4 | $66K | Sell |
435
-22
| -5% | -$3.34K | 0.01% | 470 |
|
|
2020
Q3 | $62K | Hold |
457
| – | – | 0.01% | 436 |
|
|
2020
Q2 | $62K | Buy |
457
+22
| +5% | +$2.99K | 0.01% | 406 |
|
|
2020
Q1 | $47K | Buy |
+435
| New | +$47K | 0.01% | 415 |
|